Oxaliplatin plus high-dose folinic acid and 5-fluorouracil i.v. bolus (OXAFAFU) versus irinotecan plus high-dose folinic acid and 5-fluorouracil i.v. bolus (IRIFAFU) in patients with metastatic colorectal carcinoma: a Southern Italy Cooperative Oncology Group phase III trial

Publication | Open Access

DOI Full Paper Access

Citations

References

2005

Year

P. Comella, B. Massidda, Gianfranco Filippelli, S. Palmeri, D. Natale, A. Farris, Ferdinando De Vita, Franco Buzzi, Salvatore Tafuto, Luigi Maiorino,

Annals of Oncology

OncologyMedicineHigh-dose Folinic AcidColorectal CancerMolecular Oncology5-Fluorouracil I.vCancer TreatmentIii TrialPharmacologyRadiation OncologyCancer Research